Teva Pharmaceuticals Marc A. Goshko Memorial Grant Program
Boston, August 17, 2015 -- It is with great honor that Teva Pharmaceuticals announces the re-establishment of the Teva Pharmaceuticals Scholars Grants Program as the: Teva Pharmaceuticals Marc A. Goshko Memorial Grant Program.
Marc Aaron Goshko was born on August 15, 1956 in Philadelphia, PA. He held a BS degree in Biology from Upsala College and an M.S in Microbiology from Drexel University. Marc joined Teva Pharmaceuticals in 1986 in the Regulatory group. During his 27 years with Teva, Marc built the foundations in the US for the Government Affairs, Clinical Trials, Project Management, Biopharmaceuticals, and Intellectual Property groups, as well as managing these functions. He was well-respected among top regulatory attorneys and the FDA, and was regarded as highly knowledgeable in the Hatch-Waxman and the Biologics Price Competition and Innovation Acts. Marc was promoted to Vice President, Product and Patent Strategy as part of Teva’s Legal Group. Surprisingly, Marc had no formal legal training. His zest for life, thirst for knowledge, endless curiosity and keen intellect made him a formidable opponent as well as an amazing teacher. Marc had a true gift for taking the most complex of issues and making it easy for anyone to understand. He took great joy in being able to provide insight into any topic and always made time to help whenever he was asked.
Marc passed away in November 2013, and is survived by his wife Terri, his son Ben, and his daughter-in-law Lisa Dase. His generosity of spirit and self are only a part of Marc’s legacy. For those of us who were lucky enough to have worked with Marc, his knowledge, perspective, advice and sense of humor are truly missed.
During his time at Teva, Marc and his group took on the task of initiating a Teva-supported grant program that would provide research funds to recently tenured university professors whose work was related to organic and medicinal chemistry. Since 2008, six professors have been awarded a total of $1.8 million to pursue research in areas such as natural product synthesis, liposomes, modification of microRNA and synthetic lectins. Today, we are also pleased to announce the three winners of the 2015-2018 Teva Pharmaceuticals Mark A. Goshko Memorial Grant Program.